Stethee Pro 1 vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Stethee Pro 1

by M3DICINE Pty Ltd.

EchoNext

by Pathway Labs

AI Verdict

Stethee Pro 1 is an AI-enabled digital stethoscope for real-time cardiac and respiratory vital sign analysis, ideal for point-of-care diagnostics and telemedicine. EchoNext, on the other hand, is an AI tool that analyzes standard ECGs to detect hidden structural heart disease, serving as a clinical decision support tool for early detection. While both focus on cardiac health with AI, their methodologies and primary use cases differ significantly, making them complementary rather than direct competitors.

Choose Stethee Pro 1 if…

Choose Stethee Pro 1 if you need a highly portable, AI-enabled digital stethoscope for real-time cardiac and respiratory vital sign analysis during patient examinations or telemedicine consultations. It excels at quickly capturing and visualizing heart and lung sounds with advanced amplification and filtering, providing quantitative data for immediate clinical insights and secure sharing.

View Stethee Pro 1 →

Choose EchoNext if…

Choose EchoNext if your primary goal is to screen for hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, using standard 12-lead ECGs. This AI tool is ideal for broad access screening in various clinical settings, from major hospitals to community practices, to identify patients who require further evaluation with an echocardiogram.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Stethee Pro 1	EchoNext
Pricing	$499 (device); subscription for stethee central web portal	Starts at $600/month
Deployment	Cloud-based (Stethee Central Web Portal) and mobile application (iOS/Android)	Available through the OpenEvidence clinical decision support platform.
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Stethee Pro 1

Stethee Pro 1 is designed for ease of use, capturing cardiac and respiratory vital signs in just 20 seconds, significantly reducing the time compared to traditional methods. Its intuitive mobile and web applications, along with a patented user interface, make data visualization, recording, playback, and sharing straightforward. EchoNext, while integrated into the OpenEvidence platform, is an AI analysis tool for existing ECGs, and its direct user interaction for data input is less prominent than Stethee Pro 1's device-centric approach.

Clinical Value

EchoNext

EchoNext demonstrates superior clinical value by detecting hidden structural heart disease from standard ECGs with higher accuracy than cardiologists, even those assisted by AI. This capability can lead to earlier diagnosis of serious conditions like heart failure and valve disease, potentially improving patient outcomes significantly. Stethee Pro 1 offers real-time vital sign analysis and amplification, which is valuable for diagnostics and telemedicine, but EchoNext's ability to uncover previously undiagnosed conditions from a routine test presents a more profound clinical impact.

Pricing & Value

Stethee Pro 1

Stethee Pro 1 has a clear upfront device cost of $499, with a subscription for its web portal. EchoNext's pricing starts at $600/month with tiered plans and additional fees, which could be a higher barrier to entry for smaller practices or individual clinicians. While EchoNext's value in detecting hidden heart disease is high, Stethee Pro 1's transparent and lower initial cost makes it more accessible.

Enterprise Readiness

EchoNext

EchoNext is deployed through the OpenEvidence clinical decision support platform, which serves over 650,000 U.S. physicians, indicating a strong existing infrastructure for broad adoption and integration within healthcare systems. Pathway Labs is also actively expanding deployment across health systems and growing its clinical and commercial teams. Stethee Pro 1 offers a HIPAA-compliant web portal and data sharing, but its enterprise readiness appears more focused on individual clinician use and telemedicine rather than large-scale health system integration.

Innovation

EchoNext

EchoNext represents a significant innovation by utilizing AI to detect a broad range of hidden structural heart diseases from standard ECGs, a capability that has historically been limited to more expensive and less accessible imaging techniques like echocardiography. This approach has shown to outperform cardiologists in diagnostic accuracy. Stethee Pro 1 is innovative as the world's first AI-enabled wireless digital stethoscope, offering real-time vital sign analysis and advanced amplification, but EchoNext's ability to derive such critical insights from a widely available and inexpensive test like an ECG is a more disruptive innovation in early disease detection.

Support & Docs

Tie

Both tools provide documentation and support. Stethee Pro 1 offers a comprehensive online support section with getting started guides, FAQs, and tutorials for its hardware and software. EchoNext, being integrated into the OpenEvidence platform and developed by a company with strong academic ties, likely benefits from robust technical and clinical support, though specific details on publicly available documentation are less explicit.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Stethee Pro 1	EchoNext
Name	Stethee Pro 1	EchoNext
Company	M3DICINE Pty Ltd.	Pathway Labs
Description	Stethee Pro 1 is an FDA-cleared, AI-enabled wireless digital stethoscope system by M3DICINE, providing real-time cardiac and respiratory vital sign analysis, advanced amplification, and secure data sharing for enhanced diagnostics and telemedicine.	EchoNext is an FDA-cleared AI tool from Pathway Labs that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.
Key Features	AI-enabled wireless digital stethoscope system, Captures cardiac and respiratory vital signs in 20 seconds, Measures systole, diastole, heart cycle durations, and respiration rate, Sophisticated sound amplification (up to 96x) and 5 proprietary digital filters, Real-time visualization of heart (PCG, AIDA Cycle, AIDA Energy) and lung sounds (spectrogram), Mobile app (iOS and Android) and HIPAA compliant Central Web Portal, Secure data capture, analysis, recording, playback, and sharing capabilities, Automatic geo-location and environmental data tagging (humidity, temperature, pollen count, pollution)	AI-powered ECG analysis, Detection of hidden structural heart disease, Identifies heart failure risk, Screens for valve disease, Detects pulmonary hypertension indicators, Utilizes standard 12-lead ECGs, FDA-cleared technology, Non-invasive diagnostic support

Videos

Demos, reviews, and walkthroughs featuring Stethee Pro 1 and EchoNext.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools fit into existing clinical workflows for cardiac and respiratory assessment?

Stethee Pro 1 is an AI-enabled wireless digital stethoscope system that captures cardiac and respiratory vital signs in 20 seconds, aiming to increase productivity and improve workflow during clinical examinations and remote health assessments. It allows for real-time visualization of heart and lung sounds and can generate and save patient vital sign reports directly into an EHR. EchoNext, on the other hand, analyzes standard ECGs to detect hidden structural heart disease and is integrated into the OpenEvidence clinical decision support platform, allowing its screening output to be directly accessible within a tool many physicians already use.

What is the depth of EHR integration for each tool, and how does it facilitate data management?

Stethee Pro 1's HIPAA-compliant Central Web Portal and mobile applications allow for secure data capture, analysis, recording, playback, and sharing. It can generate and save patient vital sign reports directly into an EHR. EchoNext is available through the OpenEvidence clinical decision support platform, which integrates its screening output directly into common clinical workflows, suggesting a streamlined approach to data access and utilization within existing systems.

What are the reported accuracy and sensitivity of each tool in detecting relevant conditions?

Stethee Pro 1's AI algorithms are clinically validated to accurately measure systole, diastole, heart cycle durations, and respiration rate in 20 seconds, with its respiration rate detection algorithm showing 99.9% correlation with capnography. EchoNext has demonstrated high accuracy in detecting structural heart disease, achieving an AUROC of 85.2% in internal tests and 78-80% in external validation. In studies, EchoNext alone achieved 77% accuracy in identifying structural heart problems from ECGs, outperforming cardiologists who achieved 64% accuracy, and even cardiologists assisted by AI who reached 69% accuracy.

For which medical specialties are these tools best suited, and what specific clinical insights do they provide?

Stethee Pro 1 is designed for cardiology, emergency medicine, and pulmonology, providing advanced amplification and filtering of heart and lung sounds, real-time visualization of cardiac and respiratory vital signs, and environmental data tagging. EchoNext is suited for cardiology, family medicine, hospital medicine, and internal medicine, focusing on detecting hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, from standard ECGs.

What is the learning curve for physicians adopting these tools, and what kind of support is available?

Stethee Pro 1 is designed to be easy to use, with an intuitive user interface that displays data in an easy-to-understand manner. It is built for practical use in fast-paced environments. EchoNext's integration with the OpenEvidence platform suggests it aims for ease of adoption by leveraging a tool many physicians already use, potentially reducing the learning curve.

Are there audit-trail features available to track usage and data access for accountability?

Stethee Pro 1's secure data capture, analysis, recording, playback, and sharing capabilities, along with its HIPAA compliance, imply the necessity of audit-trail features for accountability, though specific details are not provided. EchoNext's integration into a clinical decision support platform and its HIPAA compliance would also necessitate robust audit-trail features to track access and usage of patient data, but specific features are not detailed in the provided information.